SRS Capital Advisors »

Kalvista Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 971 12.18

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Frazier Life Sciences Management
Suvretta Capital Management
Capital World Investors
BlackRock
Vanguard Group
Millennium Management
Woodline Partners
Goldman Sachs Group
Parkman Healthcare Partners
Caption Management
State Street Corporation
Silverarc Capital Management
Emerald Advisers

View all funds holding Kalvista Pharmaceuticals